- Further increasing investment in Wuxi, with plans to expand with a new production line within the next two years and steadily scale up production over five years
- Domestic photon-counting CT makes a major debut, aiding early disease screening and precision diagnosis and treatment
- Reaches cooperation with Baoshan Iron & Steel Co., Ltd. to empower industrial chain upgrades with green technology
BeijingJune 22, 2026 /PRNewswire/ — During a critical period driven by the “15th Five-Year Plan” to promote technological innovation and industrial upgrading, China’s high-end medical equipment industry is accelerating its progress toward a new phase of safety, resilience, and high-quality development. As a globally leading medical technology company, Siemens Healthineers has steadfastly deepened its presence in the Chinese market for over three decades, continuously advancing localization across the entire value chain. To further demonstrate its firm commitment to supporting the deep integration and upgrading of China’s healthcare industry and supply chains, Siemens Healthineers is participating in the China International Supply Chain Expo (CISCE) for the first time this year. During the 4th CISCE, under the theme “Smart Chain for Health, Co-Creating a New Horizon,” Siemens Healthineers showcased its achievements in areas such as the layout of six R&D and manufacturing bases, innovation in domestic high-end medical equipment, and comprehensive green and sustainable development, vividly illustrating the development landscape of China’s medical industry moving toward innovation and quality.
Siemens Healthineers Booth at the 4th CISCE
Wang Hao, President of Siemens Healthineers Greater China and Member of the Global Leadership Council, stated: “The CISCE is becoming an important platform for promoting global supply chain cooperation. We hope to take this opportunity to showcase Siemens Healthineers’ achievements in supply chain localization, medical technology innovation, and green sustainable development. Looking ahead to the ’15th Five-Year Plan,’ Siemens Healthineers will continue to embed its technological roots in Chinese soil. Through deep localization of the entire value chain, we resonate with the national strategy of ‘strengthening and supplementing the chain,’ acting as a steadfast ‘co-builder’ of China’s healthcare industry chain.”
China has always been a core hub for Siemens Healthineers’ global innovation and manufacturing. Today, the company has built a complete value chain with a localization rate of over 80% for its supply chain, featuring six R&D and manufacturing bases, with over 150 products localized and exported to more than 150 countries and regions worldwide. At this expo, Siemens Healthineers presented a comprehensive overview of its achievements in full value chain localization: In Beijing, the oncology medical base has achieved a complete closed loop from core components to complete machines and from hardware to software, becoming the world’s most comprehensive radiotherapy R&D and manufacturing center. In the Greater Bay Area, the Shenzhen base, as the only base in the company’s global MR business with a complete value chain, possesses full-chain R&D and production capabilities from 1.5T to 7T, achieving localization of the entire MR system line and serving as a core global supply source for high-end MR equipment.
Increasing Investment to Further Deepen Localization of Core Components and High-End Medical Devices
On the first day of the CISCE, Siemens Healthineers’ Wuxi R&D and manufacturing base signed an investment cooperation agreement with the Management Committee of Wuxi National High-Tech Industrial Development Zone, announcing further increased investment in Wuxi to deepen the investment and layout of core components for high-end medical devices in China. The Wuxi base is a key stronghold for Siemens Healthineers in advancing full value chain localization. In recent years, the Wuxi base has achieved breakthroughs in localizing core components for high-end imaging equipment, including X-ray tubes and high-voltage generators for high-end CT, X-ray tubes and high-voltage generators for high-end cardiovascular machines, X-ray tubes and high-voltage generators for general radiography, and core components for radiotherapy equipment. The implementation of these local innovations not only accelerates Siemens Healthineers’ localization pace but also provides high-quality key components to numerous Chinese local medical imaging equipment companies, continuously injecting development momentum into the upstream and downstream industrial chains and building a more competitive modern medical equipment industry ecosystem.
Wang Hao explained: “Our efforts to localize core components are not only a strategic choice for the company but also a necessary requirement to enhance and ensure the safety and resilience of the domestic high-end medical equipment industry and supply chains.”
With over three decades of deep cultivation, Siemens Healthineers has collaborated with local partners to overcome technical barriers in localizing core components, continuously deepening supply chain and industrial chain cooperation. Together with numerous local enterprises, it has helped them join the ranks of world-class companies, leveraging Siemens Healthineers’ global network to accelerate “Made in China” onto the world stage. “Chinese wisdom, global co-creation! We have achieved a positive interaction between domestic and international dual circulation. By continuously deepening industrial and supply chain cooperation, we are actively building an innovation ecosystem with Chinese partners, jointly maintaining the stability of supply chains in China and globally,” Wang Hao added.
Deepening Layout, Domestic Photon-Counting CT Makes Major Debut
At this CISCE, Siemens Healthineers’ domestic wide-bore photon-counting CT, the NAEOTOM Alpha.Prime, made a major debut. As a benchmark technology in high-end medical equipment, the localization breakthrough of photon-counting CT not only marks a significant improvement in China’s technological autonomy in the high-end medical imaging field but also aids early disease screening and precision diagnosis and treatment by continuously advancing its high-resolution imaging capabilities, covering multiple clinical scenarios such as cardiovascular, oncology, neurology, and radiotherapy positioning. This year, Siemens Healthineers will launch two photon-counting CT products in China, providing important support for high-quality innovation and supply chain upgrades in China’s high-end medical equipment sector.
Particularly noteworthy is that in the future industry of brain-computer interfaces, a forward-looking area outlined in the “15th Five-Year Plan,” Siemens Healthineers is deeply laying out its product technology advantages. The NAEOTOM Alpha series, with its ultra-high resolution, significantly enhances imaging capabilities for the skull and cerebral blood vessels, improving structural imaging clarity and visualization for preoperative risk assessment, providing core imaging solutions for clinical research and implementation of brain-computer interfaces. Meanwhile, Siemens Healthineers is also establishing collaborations with several renowned neurology hospitals and startups, leveraging its leading medical imaging platform to jointly conduct clinical and scientific research translation for brain-computer interfaces, creating an innovation hub for brain science.
This year, Siemens Healthineers expects to localize two photon-counting CT models. This is not merely a capacity transfer but a deep integration of global technology with local industry, clinical, and supply chain ecosystems. Leveraging a dedicated production line at the Shanghai base and a full-cycle local team covering definition, R&D, registration, production, and service, Siemens Healthineers has built an autonomous and controllable full-chain operation system. This not only significantly enhances the accessibility and supply chain resilience of high-end equipment but also drives suppliers up the value chain, accelerating the industry’s move toward precision, intelligence, and high-end development.
Partnering with Baoshan Iron & Steel Co., Ltd. to Promote Low-Carbon and Eco-Friendly Development in Medical Devices
Guided by the national “dual carbon” strategy, green transformation has become a necessary path for the high-quality development of the medical device industry. On the first day of the CISCE, Siemens Healthineers’ Shanghai R&D and manufacturing base signed a technological innovation cooperation agreement with Baoshan Iron & Steel Co., Ltd. The focus will be on low-carbon material applications, digital simulation, and mechanical design innovation to drive green technology breakthroughs and reduce carbon emissions throughout the lifecycle of medical equipment. This collaboration underscores Siemens Healthineers’ determination to empower industrial chain upgrades with green technology.
During the expo, Siemens Healthineers’ “Green Zone” showcased the company’s practical achievements in sustainable development: The innovative DryCool dry magnet technology reduces energy consumption of MR systems by over 40%, with liquid helium consumption dropping from 1,500 liters to 0.7 liters. The Shanghai, Shenzhen, and Beijing bases have all been recognized as “2024 National Green Factories.” In the future, Siemens Healthineers will continue to optimize full-process green management, using green engines to support the intelligent upgrade of China’s medical industry.
As a participant and enabler of high-quality development in China’s medical industry, Siemens Healthineers is deeply integrating into China’s development blueprint through full-chain innovation, local collaboration, and green transformation. Looking ahead, the company will seize the strategic opportunities of the “15th Five-Year Plan,” leveraging policy support and industrial advantages to continuously expand its innovation network and industrial cooperation landscape in China, driving more innovative achievements to fruition, and contributing global wisdom and Chinese solutions to building a safe, resilient, and sustainable healthcare ecosystem.
Note: The domestic wide-bore photon-counting CT NAEOTOM Alpha.Prime has not yet obtained NMPA approval and is for display purposes only at this expo.
Disclaimer: This article is a press release aimed at introducing the company’s exhibition activities and does not constitute any commercial promotion or product usage advice.
About Siemens Healthineers
Innovating for every life. Siemens Healthineers is a globally leading medical technology company providing medical equipment, solutions, and services, with operations in over 180 countries and regions and direct business in more than 70 countries and regions. Siemens Healthineers is composed of Siemens Healthineers AG (Frankfurt Stock Exchange ticker: SHL) and its subsidiaries. The company is committed to improving access to high-quality healthcare while combating life-threatening diseases. Siemens Healthineers’ business covers medical imaging, in-vitro diagnostics, cancer care, and minimally invasive therapies, and it strengthens its capabilities through digital technology and artificial intelligence. As of fiscal year 2025 (ending September 30, 2025), Siemens Healthineers had approximately 74,000 employees worldwide and generated revenue of around €23.4 billion. For more information, please visit Siemens Healthineers’ official website: www.siemens-healthineers.com